|
4WUR
The crystal structure of the MERS-CoV papain-like protease (C111S) with human ubiquitin
Deposited 2014-11-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1482–1801(320 aa)
Fragment:UNP residues 1482-1801
|
Mutation:C111S
|
IPA ISOPROPYL ALCOHOL × 2
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.8;291 K;22% w/v PEG 4000, 15% v/v 2-propanol, 0.1M tri-sodium citrate pH 4.8 and 10% glycerol
|
Resolution 3.16 Å
R-free 0.252
|
|
8PPL
MERS-CoV Nsp1 bound to the human 43S pre-initiation complex
Deposited 2023-07-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 50
PDB declaration: 52-meric
|
Chain Aj
2–193(192 aa)
|
Not recorded
|
ZN ZINC ION × 4
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 116
MET METHIONINE × 1
UNX UNKNOWN LIGAND × 129
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 2.65 Å
|
|
9INM
Crystal structure of MERS main protease in complex with Bofutrelvir
Deposited 2024-07-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3248–3548(301 aa)
Chain D
3248–3548(301 aa)
|
Not recorded
|
FHR ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.2M Sodium formate, 0.1M BICINE pH8.5 20% PEG5000
|
Resolution 2.34 Å
R-free 0.275
|
|
9INM
Crystal structure of MERS main protease in complex with Bofutrelvir
Deposited 2024-07-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
3248–3548(301 aa)
Chain C
3248–3548(301 aa)
|
Not recorded
|
FHR ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.2M Sodium formate, 0.1M BICINE pH8.5 20% PEG5000
|
Resolution 2.34 Å
R-free 0.275
|
|
9PAC
Crystal structure of MERS-CoV 3CLpro with ALG-097608 (Inhibitor 1)
Deposited 2025-06-25
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
3248–3553(306 aa)
Chain D
3248–3553(306 aa)
|
Not recorded
|
A1CHF (1R,2R,3S,6S,7S)-4-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-10,10-difluoro-N-{(1E,2R)-1-imino-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-4-azatricyclo[5.2.1.0~2,6~]decane-3-carboxamide (non-preferred name) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M NaCl, Sodium/Potassium Phosphate 6.2, and 18% PEG1000
|
Resolution 2.28 Å
R-free 0.269
|
|
9PAC
Crystal structure of MERS-CoV 3CLpro with ALG-097608 (Inhibitor 1)
Deposited 2025-06-25
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3248–3553(306 aa)
Chain B
3248–3553(306 aa)
|
Not recorded
|
A1CHF (1R,2R,3S,6S,7S)-4-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-10,10-difluoro-N-{(1E,2R)-1-imino-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-4-azatricyclo[5.2.1.0~2,6~]decane-3-carboxamide (non-preferred name) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M NaCl, Sodium/Potassium Phosphate 6.2, and 18% PEG1000
|
Resolution 2.28 Å
R-free 0.269
|
|
9XG7
The crystal structure of MERS-CoV Main protease in complex with inhibitor FD2-21
Deposited 2025-10-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3248–3551(304 aa)
Chain B
3248–3551(304 aa)
|
Not recorded
|
A1EZ7 7-(5-azanylpyridin-3-yl)-2-(2-chlorophenyl)-5,7-diazaspiro[3.4]octane-6,8-dione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289.15 K;0.05 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 30% v/v Polyethylene glycol monomethyl ether 550
|
Resolution 2.53 Å
R-free 0.298
|
|
9XG7
The crystal structure of MERS-CoV Main protease in complex with inhibitor FD2-21
Deposited 2025-10-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
3248–3551(304 aa)
Chain D
3248–3551(304 aa)
|
Not recorded
|
A1EZ7 7-(5-azanylpyridin-3-yl)-2-(2-chlorophenyl)-5,7-diazaspiro[3.4]octane-6,8-dione × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289.15 K;0.05 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 30% v/v Polyethylene glycol monomethyl ether 550
|
Resolution 2.53 Å
R-free 0.298
|
|
9Y8W
MERS Mpro with EGT710
Deposited 2025-09-11
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3248–3553(306 aa)
Chain C
3248–3553(306 aa)
|
Not recorded
|
A1CBU (4S)-4-(iminomethyl)-3-(isoquinolin-4-yl)-1-[6-(trifluoromethyl)pyridin-3-yl]imidazolidin-2-one × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;294 K;0.1M Hepes pH 7.5, 8% Ethylene Glycol, 10% Peg 8000
|
Resolution 3.04 Å
R-free 0.278
|
|
9Y8W
MERS Mpro with EGT710
Deposited 2025-09-11
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
3248–3553(306 aa)
Chain D
3248–3553(306 aa)
|
Not recorded
|
A1CBU (4S)-4-(iminomethyl)-3-(isoquinolin-4-yl)-1-[6-(trifluoromethyl)pyridin-3-yl]imidazolidin-2-one × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;294 K;0.1M Hepes pH 7.5, 8% Ethylene Glycol, 10% Peg 8000
|
Resolution 3.04 Å
R-free 0.278
|
|
9YCK
Cryo-EM structure of MERS-CoV nsp10-nsp14 (E191A) in complex with T20P15 RNA, monomeric form
Deposited 2025-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
4238–4377(140 aa)
Chain B
5909–6432(524 aa)
|
Mutation:E191A
|
ZN ZINC ION × 5
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
9YCL
Cryo-EM structure of MERS-CoV nsp10-nsp14 (E191A) in complex with T20P15 RNA, dimeric form
Deposited 2025-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 4
PDB declaration: hexameric
|
Chain A
4238–4377(140 aa)
Chain B
5909–6432(524 aa)
Chain D
4238–4377(140 aa)
Chain E
5909–6432(524 aa)
|
Mutation:E191A
Mutation:E191A
|
ZN ZINC ION × 10
MG MAGNESIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.50 Å
|
|
9YCM
Cryo-EM structure of MERS-CoV nsp10-nsp14 (E191A) in complex with T20P14-U RNA
Deposited 2025-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 4
PDB declaration: hexameric
|
Chain A
4238–4377(140 aa)
Chain B
5909–6432(524 aa)
Chain D
4238–4377(140 aa)
Chain E
5909–6432(524 aa)
|
Mutation:E191A
Mutation:E191A
|
ZN ZINC ION × 10
MG MAGNESIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.94 Å
|
|
9YCN
Cryo-EM structure of MERS-CoV nsp10-nsp14 (E191A) in complex with T20P14-A RNA
Deposited 2025-09-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
4238–4377(140 aa)
Chain B
5909–6432(524 aa)
|
Not recorded
|
ZN ZINC ION × 5
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.88 Å
|
|
9YCO
Cryo-EM structure of MERS-CoV nsp10-nsp14 (E191A) in complex with T20P14-G RNA
Deposited 2025-09-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
4238–4377(140 aa)
Chain B
5909–6432(524 aa)
|
Not recorded
|
ZN ZINC ION × 5
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.88 Å
|